Clinical Trials Directory

Trials / Completed

CompletedNCT01091545

Malmö Breast Tomosynthesis Screening Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15,000 (actual)
Sponsor
Region Skane · Academic / Other
Sex
Female
Age
40 Years – 74 Years
Healthy volunteers
Not accepted

Summary

To compare digital breast tomosynthesis (DBT) with full field digital mammography (FFDM) regarding effectiveness as screening modalities.

Detailed description

Mammography is the only approved method for breast cancer screening, but not all tumors can be detected with mammography. The main reason is overlapping structures that can either mimic or hide a tumor on a 2-dimensional image like mammography. Digital breast tomosynthesis, (DBT) is a 3-dimensional x-ray technique that has been developed during the last years. A tomographic technique like DBT, which reduces or eliminates the detrimental effect of over- and underlying tissue, can probably help to find more tumors. This study aims to investigate whether more breast cancers can be detected with DBT compared to full field digital mammography (FFDM) in population invited to screening. An interim analysis will be performed during 2013 including the first 7,500 women of the study cohort.

Conditions

Interventions

TypeNameDescription
RADIATIONDBT and FFDMWomen in the study will once undergo both standard FFDM screening (2-views) and DBT (1 view, MLO). This will result in a doubled radiation dose compared to only 2-view FFDM, which is the standard procedure for women in the screening program.

Timeline

Start date
2010-02-01
Primary completion
2017-12-31
Completion
2019-09-30
First posted
2010-03-24
Last updated
2019-11-13

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01091545. Inclusion in this directory is not an endorsement.

Malmö Breast Tomosynthesis Screening Trial (NCT01091545) · Clinical Trials Directory